Resultados de la búsqueda 1241-1250 of 10516 for Article

  1. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the ...

  2. Pérdida de peso - Mayo Clinic

    Necesitas perder peso? Olvídate de las dietas relámpago. Adopta hábitos de alimentación saludable y ejercicio. Es la forma inteligente de perder peso y no ...

  3. Oncología (médica) - Ensayos clínicos

    The primary purpose of this trial is to evaluate the safety \& tolerability of Nadofaragene Firadenovec in subjects with LG-UTUC.

  4. Neurología - Ensayos clínicos

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

  5. Pérdida de peso Diet pills, supplements and surgery - Mayo Clinic

    https://www.niddk.nih.gov/health-information/weight-management/bariatric-surgery/potential-candidates. Accessed March 10, 2023. May 25, 2024. Original article: ...

  6. Anglioplastia de la carótida - Mayo Clinic

    Original article: https://www.mayoclinic.org/es-es/tests-procedures/carotid-angioplasty-and-stenting/multimedia/carotid-angioplasty/img-20005935.

  7. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to design, develop and assess the performance characteristics of NGS assays using circulating tumor DNA for the detection of ...

  8. Oncología (médica) - Ensayos clínicos

    The purpose of this study is to evaouate how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) ...

  9. Oncología (médica) - Ensayos clínicos

    Rochester, Minn. Levels of bladder cancer-derived extracellular vesicles become undetectable after radical cystectomy in patients with localized bladder cancer.

  10. Oncología (médica) - Ensayos clínicos

    The primary objective of the trial is to evaluate if L19TNF in combination with doxorubicin (Arm 2) given for unresectable or metastatic soft tissue sarcoma ...